Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer
BackgroundClinically, few patients with locally advanced cervical cancer (LACC) are insensitive to neoadjuvant chemotherapy (NACT). Recent studies have reported that circulating microRNAs (miRNAs) may be involved in the response to NACT. The aim of this study was to discover the potential miRNAs tha...
Main Authors: | Kangni Zou, E. Yang, Tao Cui, Zhengyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1036710/full |
Similar Items
-
The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation
by: Yi Sun, et al.
Published: (2022-12-01) -
Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer
by: Yuhui Huang, et al.
Published: (2022-08-01) -
Dose-Intense Cisplatin-Based Neoadjuvant Chemotherapy Increases Survival in Advanced Cervical Cancer: An Up-to-Date Meta-Analysis
by: Van Tai Nguyen, et al.
Published: (2022-02-01) -
Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis
by: Neila Pierote Gaspar Nascimento, et al.
Published: (2022-08-01) -
Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to Pave
by: Chiara Benvenuti, et al.
Published: (2023-02-01)